NCT03163550View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

October 15, 2017

Study Completion Date

October 15, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

ACHN-383

Oral dose

DRUG

ACHN-789

Oral dose

DRUG

Placebo

Oral dose

Trial Locations (1)

Unknown

Clinical Site, Perth

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
lead

Achaogen, Inc.

INDUSTRY

NCT03163550 - A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789 | Biotech Hunter | Biotech Hunter